Browsing by Author Lee Jon Deoon,Edmund

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 25 to 44 of 67 < previous   next >
Issue DateTitleAuthor(s)
2004MDR1, the blood-brain barrier transporter, is associated with Parkinson's disease in ethnic ChineseLee C.G. ; Tang K.; Cheung Y.B. ; Wong L.P.; Tan C.; Shen H.; Zhao Y.; Pavanni R. ; Lee E.J. ; Wong M.C. ; Chong S.S. ; Tan E.K. 
2007Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension arrayKoo, S.H. ; Chong, K.T. ; Lee, E.J.D. ; Ong, T.C. ; Chew, F.T. ; Lee, C.G.L.
1999NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in SingaporeZhao, B. ; Lee, E.J.D. ; Teh, M.; Tan, W.-C. ; Poh, W.-T.; Eng, P.; Wang, Y.-T.; Seow, A.; Lee, H.-P.
1990Need for precise chiral nomenclatureLee, E. ; Williams, K.
2009Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the cholinesterase inhibitor pyridostigmine bromide in Chinese malesYong, S.K.; Keong, L.W.; Shabbir, M. ; Lee, J.D. 
1989NSAIDS. A consideration of their efficacy and toxicityLee, E.J.D. 
2006Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding regionWang, Z.; Lee, C.G.L. ; Sew, P.-H.; Ambrose, H.; Ryan, S.; Chong, S.S.; Lee, E.J.D. 
2006Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding regionWang, Z.; Lee, C.G.L. ; Sew, P.-H.; Ambrose, H.; Ryan, S.; Chong, S.S.; Lee, E.J.D. 
2010Oral sulfasalazine as a clinical BCRP probe substrate: Pharmacokinetic effects of genetic variation (C421A) and pantoprazole coadministrationAdkison, K.K.; Vaidya, S.S.; Mehta, A.A.; Lee, D.Y.; Polli, J.W.; Humphreys, J.E.; Koo, S.H. ; Li, L. ; Lee, E.J.D. ; Gross, A.S.; Lou, Y.
2006Pharmacogenetics approach to therapeuticsKoo, S.H. ; Lee, E.J.D. 
Sep-2000Pharmacogenetics: Role in modifying drug dosage regimensMah, J.T.L. ; Wong, J.Y.Y.; Lee, E.J.D. 
2000Pharmacogenetics: The molecular genetics of CYP2D6 dependent drug metabolismWong, J.Y.Y.; Seah, E.S.; Lee, E.J.D. 
Jan-1997Pharmacology and Toxicology of Chemical Warfare AgentsLee, E.J.D. 
2013Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in MycobacteriaSarathy J.P.; Lee E. ; Dartois V. 
1995Polymorphic inhibition of human angiotensin I-converting enzyme by enalaprilatLee, E.J.D. 
1994Population genetics of the angiotensin-converting enzyme in ChineseLee, E.J.D. 
2008Proton pump inhibitors: Do differences in pharmacokinetics translate into differences in clinical outcomes?Fock, K.M.; Ang, T.L.; Bee, L.C.; Lee, E.J.D. 
1-Nov-2008PXR pharmacogenetics: Association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patientsSandanaraj, E.; Lal, S.; Selvarajan, V. ; Ooi, L.L. ; Zee, W.W.; Nan, S.W.; Ang, P.C.S.; Lee, E.J.D. ; Chowbay, B. 
2008Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathyDorajoo, R.S.O.; Lee, E. ; Pereira, B.P. ; Yu, Z.; Gopalakrishnakone, P. ; Leong, C.C.; Wee, A. 
2008Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathyDorajoo, R.S.O.; Lee, E. ; Pereira, B.P. ; Yu, Z.; Gopalakrishnakone, P. ; Leong, C.C.; Wee, A.